{"raw_mentions": "Unfortunately, there are no sentences in the provided text that meet the specified criteria, as none of them contain a specific molecule name, ID, or other identifier, a bioactivity metric (IC50, Ki, Kd, EC50, etc.), a specific numeric value for that metric, and a unit for that value. \n\nIf you'd like, I can try to help with anything else."}
{"final_json": [{"molecule_name": null, "protein_target_name": null, "binding_metric": null, "value": null, "unit": null}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nPeptides of the invention were labelled with a fluorescent tag (fluorescein, Fl) and diluted to 2.5nM in 50mM HEPES with 100mM NaCI and 0.05% tween pH 7.5.\nCD137 protein was titrated starting at 3\u03bc\u039c in the same assay buffer as the peptide to assay 1 nM peptide in a total volume of 25\u03bc\u03af in black walled and bottomed low bind low volume 384 well plates.\nThe concentrations of CD137 protein were 1 in 2 serial dilutions to give 12 different concentrations starting at 3\u03bc\u039c.\nThe peptides were tested at starting concentrations of 300-450 nM and diluted in \u00bd dilutions series.\nThe top peptide concentration was 500nM or 10\u03bc\u039c with 6 further 3-fold (500nm), or 2-fold (10\u03bc\u039c) dilutions in PBS/0.05% Tween 20."}
{"final_json": [{"molecule_name": "peptides", "protein_target_name": null, "binding_metric": null, "value": null, "unit": null}, {"molecule_name": "fluorescein (Fl)", "protein_target_name": null, "binding_metric": null, "value": "2.5", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "CD137 protein", "binding_metric": null, "value": "3", "unit": "\u03bcM"}, {"molecule_name": null, "protein_target_name": "CD137 protein", "binding_metric": null, "value": "1", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "CD137 protein", "binding_metric": null, "value": "3", "unit": "\u03bcM"}, {"molecule_name": "peptides", "protein_target_name": null, "binding_metric": null, "value": "300-450", "unit": "nM"}, {"molecule_name": "peptides", "protein_target_name": null, "binding_metric": null, "value": "500", "unit": "nM"}, {"molecule_name": "peptides", "protein_target_name": null, "binding_metric": null, "value": "10", "unit": "\u03bcM"}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* Dilute agonists at concentration giving agonism CD137L (R&D systems 2295-4L/CF) diluted to 100 nM in the RPMI-1640 medium as final concentration in the assay.\n* Suggested starting concentration for the bicyclic peptide is 10 \u03bc\u039c, 100-fold excess over the agonist CD137L.\n* The competitor agonists CD137L (R&D systems), Urelumab and Utomilumab were diluted in assay buffer 20mM HEPES, 150mM NaCI, 0.05% P20, pH7.5 to a top concentration of 500- 1000 nM.\n* The human CD137 protein (AcroBiosystems) was diluted to 500 nM final concentration in the assay.\n* Finally, the fluorescent tracer peptide BCY640 (74-01 -04-N001) was added at 1 nM."}
{"final_json": [{"molecule_name": "CD137L (R&D systems 2295-4L/CF)", "protein_target_name": null, "binding_metric": null, "value": "100", "unit": "nM"}, {"molecule_name": "bicyclic peptide", "protein_target_name": null, "binding_metric": null, "value": "10", "unit": "\u03bc\u039c"}, {"molecule_name": "CD137L (R&D systems)", "protein_target_name": null, "binding_metric": null, "value": "500-1000", "unit": "nM"}, {"molecule_name": "Urelumab", "protein_target_name": null, "binding_metric": null, "value": "500-1000", "unit": "nM"}, {"molecule_name": "Utomilumab", "protein_target_name": null, "binding_metric": null, "value": "500-1000", "unit": "nM"}, {"molecule_name": "human CD137 protein (AcroBiosystems)", "protein_target_name": "CD137", "binding_metric": null, "value": "500", "unit": "nM"}, {"molecule_name": "BCY640 (74-01-04-N001)", "protein_target_name": null, "binding_metric": null, "value": "1", "unit": "nM"}]}
